Luke brings investment and leadership experience, having previously served as chief executive and founder at IW Capital and on the board of the UK Business Angels Association.
CS
Chris Soames
Investor Director
Chris brings investment and finance experience from roles at IW Capital, Heritage Capital, and Deutsche Bank. He focuses on sourcing, executing, and managing SEIS and EIS investments.
Charlie serves as investment director at IW Capital and holds board experience across several companies. He previously worked as chief investment officer at Bike Club and principal at Codex Capital Partners.
David brings extensive venture capital and investment management experience from roles at IW Capital, Edge Investments, and Elderstreet Investments. He previously served as an investment manager and consultant across several firms.
The funding round was led by IW Capital with support from existing investors IP Group and Mercia Ventures.
"Electrosurgical tools have transformed modern surgery but also generate surgical smoke that affects the quality and efficiency of surgery and poses risks to operating theatre staff. For years, available solutions have required trade-offs between effectiveness and workflow disruption, slowing adoption across the industry. As awareness grows that smoke management is integral to surgical safety and efficiency, solutions that tackle smoke at its source are becoming increasingly important for supporting the next generation of minimally invasive and robotic procedures."
The funding round included participation from XTX Ventures and Macmillan Cancer Support to accelerate deployment and expand diagnostics.
"Cancer imaging volumes are rising rapidly but reporting capacity is not keeping pace. Our goal is to give clinicians faster, more confident decisions while reducing unnecessary interventions for patients. With our deep focus on prostate cancer and strong clinical validation across NHS pathways, we’re showing how AI can deliver earlier and more accurate diagnoses. In the NHS, few Trusts can confirm or rule out cancer within 28 days, and some patients can wait two months or longer. Lucida Medical is ideally placed to reduce this burden, and this funding will allow us to do that faster."
IW Capital led the investment round to support product development and commercial scaling.
"Navigator is solving one of the most urgent challenges in digital marketing how to deliver effective advertising in a world where privacy is paramount. With exclusive access to rich data, a proven commercial model, and a leadership team with deep industry experience, Navigator is perfectly positioned to scale. We’re excited to support its next stage of growth."
The Series A round was led by IW Capital and will fund sales growth and product development.
"IW Capital are thrilled to announce our investment into Strolll. Strolll are transforming the physiotherapy and neurorehabilitation markets and have already helped a significant number of people with debilitating neurological disorders to live better lives. The potential impact of their software is huge and we’re proud to be backing this cutting-edge business as it addresses key healthcare needs."
The London-based home fitness startup raised $5m in a round led by IW Capital to scale operations and expand into new markets.
"Magic AI serves the home fitness market with unique and proprietary AI fitness technology. The company has a loyal user base, a unique technology proposition, and an exciting roadmap ahead."
.png)